Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?

The continuous spread of carbapenem-resistant Klebsiella pneumoniae (CP-Kp) strains presents a severe challenge to the healthcare system due to limited therapeutic options and high mortality. Since its availability, ceftazidime/avibactam (C/A) has become a first-line option against KPC-Kp, but C/A-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Corcione, Silvia, De Benedetto, Ilaria, Shbaklo, Nour, Torsello, Giulia, Lupia, Tommaso, Bianco, Gabriele, Cavallo, Rossana, Brazzi, Luca, Montrucchio, Giorgia, De Rosa, Francesco Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002972/
https://www.ncbi.nlm.nih.gov/pubmed/36902196
http://dx.doi.org/10.3390/ijms24054767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002972/
https://www.ncbi.nlm.nih.gov/pubmed/36902196
http://dx.doi.org/10.3390/ijms24054767

Ejemplares similares